From: The European challenges of funding orphan medicinal products
Austria | Federation of Austrian Social Insurance Institutions (Hauptverband der österreichischen Sozialversicherungsträger) |
Belgium | National Institute for Health and Disability Insurance of Belgium (Institut National d’Assurance Maladie-Invalidité / Rijksinstituut voor ziekte-en invaliditeitsverzekering, INAMI / RIZIV) |
Bulgaria | National Health Insurance Fund (NHIF) National Council on Prices and Reimbursement of Medicinal Products (NCPR) |
Czech Republic | State Institute for Drug Control (Státní ústav pro kontrolu léčiv, SUKL) |
France | French National Authority for Health (Haute Autorité de Sante, HAS) |
Hungary | National Health Insurance Fund Administration of Hungary (Országos Egészségbiztosítási Pénztár, OEP) |
Poland | National Health Fund (Narodowy Fundusz Zdrowia), Ministry of Health (Ministerstwo Zdrowia) |
Slovenia | Health Insurance Institute of Slovenia (Zavod za zdravstveno zavarovanje Slovenije, ZZZS) |